Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a late-stage trial. The company said its psilocybin drug reduced depression ...

For decades, psychedelics were synonymous with counterculture and elicited fierce political backlash. Today, compounds derived from psychoactive substances such as psilocybin and lysergic acid ...

Add Yahoo as a preferred source to see more of our stories on Google. Psychedelics have a long and rich history in human culture, with archaeologists estimating that humans first started consuming ...

A hand in a blue glove plucks a white mushroom from a dense stand of mushrooms. Mature magic mushrooms are carefully harvested to minimize damage. Credit: Filament Health Some scientists theorize that ...

The first peer-reviewed journal to publish original research papers on every aspect of psychedelic medicine including basic science, clinical, and translational research. The theory that sacred ...

As the field of mental health continues to evolve, psychedelic drugs are increasingly undergoing rigorous scientific research for their therapeutic potential. Molecules like psilocybin, MDMA, and DMT ...

Beckley Psytech’s psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study, triggering the next stage of a planned merger with mental health-focused company Atai Life ...

While there's growing evidence that psychedelic drugs can effectively treat severe mental health conditions, especially in cases where traditional treatments have failed, they still come with ...

AbbVie has agreed to acquire Gilgamesh Pharmaceuticals’ lead pipeline asset bretisilocin, a clinical-stage candidate designed to treat moderate-to-severe major depressive disorder (MDD), for up to ...

Experts on psychedelic use and drug regulation discussed whether psychedelic therapy should be legalized federally at a Wednesday event hosted by the Petrie-Flom Center for Health Law Policy, ...